High plasma fibroblast growth factor 19 is associated with improved prognosis in patients with acute ischemic stroke
Clinical Nutrition · 2025
DOI: 10.1016/j.clnu.2025.03.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Xiao Ren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Research Center and Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 2…. Hauptthemen laut MEDLINE: Ischemic Stroke, Fibroblast Growth Factors, Brain Ischemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
OBJECTIVE: To prospectively investigate the relationships between plasma fibroblast growth factor 19 (FGF-19) and clinical outcomes in patients with acute ischemic stroke. METHODS: Plasma FGF-19 levels at baseline were measured for 3048 patients with ischemic stroke, and all patients were followed up at one year after stroke onset. The primary outcome was a combination of death and major disability (modified Rankin Scale score of ≥3) at one year after stroke onset, and secondary outcomes included major disability, death, recurrent stroke, vascular events and the combination of death and vascular events. RESULTS: During the 1-year of follow-up, 682 (22.38 %) patients experienced the primary outcome; 503 had a major disability and 179 died. After multivariate adjustment, higher plasma FGF-19 was significantly associated with decreased risk of the primary outcome (odds ratio = 0.48, 95 % confidence interval = 0.36-0.66). Each 1-SD increase of log-transformed FGF-19 (0.93 pg/mL) was associated with 20 % decreased risk of the primary outcome. The addition of FGF-19 to the conventional risk factors significantly improved prediction of the primary outcome in ischemic stroke patients (net reclassification index = 25.10 %, p < 0.001; integrated discrimination improvement = 1.25 %, p < 0.001). Furthermore, patients with both high FGF-19 (≥573.7 pg/mL) and low FGF-21 (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public Health Research Center and Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, China.
- Department of Epidemiology, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Epidemiology, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseas…
- Public Health Research Center and Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, China. Electronic address: zxw19921212@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ren, X., Yang, P., Sun, L., Jia, Y., Zhong, C., Zhang, J., Zhang, Q., Xu, T., Zheng, X., & Zhang, Y. (2025). High plasma fibroblast growth factor 19 is associated with improved prognosis in patients with acute ischemic stroke. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.03.013
Vancouver
Ren X, Yang P, Sun L, Jia Y, Zhong C, Zhang J, et al. High plasma fibroblast growth factor 19 is associated with improved prognosis in patients with acute ischemic stroke. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.03.013
BibTeX
@article{Ren2025,
author = {Ren, Xiao and Yang, Pinni and Sun, Lulu and Jia, Yiming and Zhong, Chongke and Zhang, Jing and Zhang, Qilu and Xu, Tan and Zheng, Xiaowei and Zhang, Yonghong},
title = {High plasma fibroblast growth factor 19 is associated with improved prognosis in patients with acute ischemic stroke},
journal = {Clinical Nutrition},
year = {2025},
doi = {10.1016/j.clnu.2025.03.013}
}
EUVIMED